South Korea vs Latin America & Caribbean (excluding high income): Cause of death, by non-communicable diseases, ages 15-59, male

South Korea
66.6%
in 2021
Latin America & Caribbean (excluding high income)
36.8%
in 2021
South Korea rank
41st
Latin America & Caribbean (excluding high income) rank
43rd

Cause of death, by non-communicable diseases, ages 15-59, male over time

  • South Korea
  • Latin America & Caribbean (excluding high income)
0204060200020102021

How they compare

South Korea currently reports 66.6% against 36.8% in Latin America & Caribbean (excluding high income), a difference of 29.8%.

That makes South Korea's figure about 1.8 times Latin America & Caribbean (excluding high income)'s.

Across all 6 years both countries report, South Korea has been ahead every year.

South Korea ranks 41st and Latin America & Caribbean (excluding high income) ranks 43rd of 185 countries.

South Korea has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade South Korea Latin America & Caribbean (excluding high income) Difference Ahead
2000s 66.7% 46.7% 20.1% South Korea
2010s 65.9% 48.6% 17.3% South Korea
2020s 67.1% 39.4% 27.6% South Korea

Averages of every year both report within each decade.

Frequently asked questions

Which has higher cause of death, by non-communicable diseases, ages 15-59, male, South Korea or Latin America & Caribbean (excluding high income)?
South Korea, at 66.6% against 36.8% in Latin America & Caribbean (excluding high income) as of 2021.
What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between South Korea and Latin America & Caribbean (excluding high income)?
29.8%, with South Korea ahead.
How many years of comparable data are there for South Korea and Latin America & Caribbean (excluding high income)?
6 years are reported by both, from 2000 to 2021.
How do South Korea and Latin America & Caribbean (excluding high income) rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
South Korea ranks 41st and Latin America & Caribbean (excluding high income) ranks 43rd of 185 countries.
Where does this data come from?
Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

South Korea vs Latin America & Caribbean (excluding high income): Cause of death, by non-communicable diseases, ages 15-59, male. Statizoid, drawing on Global Health Estimates, World Health Organization (WHO). Retrieved 19 September 2026, from https://health.statizoid.com/compare/cause-of-death-by-non-communicable-diseases-ages-15-59-male-percent-of-total-male-deaths/korea-rep/latin-america-and-caribbean-excluding-high-income/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/cause-of-death-by-non-communicable-diseases-ages-15-59-male-percent-of-total-male-deaths/korea-rep/latin-america-and-caribbean-excluding-high-income/">South Korea vs Latin America & Caribbean (excluding high income): Cause of death, by non-communicable diseases, ages 15-59, male</a> — Statizoid

About this data

Indicator
Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59)
Unit
% of total male deaths ages 15-59
Source
Global Health Estimates, World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 1,392 data points, 2000–2021
Last refreshed

Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.